{
  "abstract": "Evidence on the real-world effectiveness of seasonal influenza vaccination among older adults in China remains limited and varies by season and circulating virus. We used a test-negative case–control design to estimate the effectiveness of the 2025–2026 trivalent influenza vaccine against medically attended, laboratory-confirmed influenza among adults aged ≥60 years attending two sentinel hospitals in Shengzhou, Zhejiang Province. Participants vaccinated ≥14 days before symptom onset were considered vaccinated; those vaccinated 0–13 days before onset were excluded from the primary analysis. Vaccine effectiveness (VE) was calculated as (1 − adjusted odds ratio) × 100% using multivariable logistic regression. Among 532 participants in the primary analysis, 156 were influenza-positive cases and 376 were test-negative controls. Effective current-season vaccination was recorded in 32.7% of cases and 48.4% of controls. Adjusted VE against any influenza was 46% (95% confidence interval [CI], 18–64). Type-specific VE was 42% (95% CI, 8–63) against influenza A and 60% (95% CI, 14–81) against influenza B. Subtype-specific estimates were less precise, and interaction analyses did not identify differences by age group or chronic-disease status. The overall estimate remained stable across diagnostic restrictions and alternative model specifications. The 2025–2026 trivalent influenza vaccine was associated with moderate protection against medically attended influenza in older adults under routine program conditions, supporting continued seasonal vaccination and multi-season surveillance.",
  "abstract_shown": true,
  "affiliations": [
    "Department of Immunity, Shengzhou Center for Disease Control and Prevention, Shengzhou, Zhejiang, China"
  ],
  "article_type": "research article",
  "arxiv": null,
  "author_total": 6,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "Yugang Shen",
      "orcid": "0009-0003-5512-2515"
    },
    {
      "affs": [
        0
      ],
      "name": "Ling Zhang"
    },
    {
      "affs": [
        0
      ],
      "name": "Qianmei Liu"
    },
    {
      "affs": [
        0
      ],
      "name": "Xiaoyang Ou"
    },
    {
      "affs": [
        0
      ],
      "name": "Jiawen Qian"
    },
    {
      "affs": [
        0
      ],
      "name": "Libo Ren"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/1x0rmcqa030f8.bib",
  "cited_by": 0,
  "doi": "10.1080/21645515.2026.2759393",
  "fulltext_url": "https://pmc.ncbi.nlm.nih.gov/articles/PMC13757678/",
  "id": "1x0rmcqa030f8",
  "issns": [
    "2164-5515",
    "2164-554X"
  ],
  "landing_url": "https://doi.org/10.1080/21645515.2026.2759393",
  "language": "en",
  "licence": "CC-BY-NC-4.0",
  "licence_label": "CC BY-NC 4.0",
  "licence_source": "article",
  "licence_url": "https://creativecommons.org/licenses/by-nc/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "heading",
      "Influenza"
    ],
    [
      "heading",
      "Research Article"
    ],
    [
      "openalex",
      "2713|Influenza Virus Research Studies"
    ]
  ],
  "openalex": "W7225596719",
  "pdf_url": "https://www.tandfonline.com/doi/pdf/10.1080/21645515.2026.2759393?needAccess=true",
  "pmcid": "PMC13757678",
  "pmid": "43000208",
  "published": "2026-11-08",
  "publisher": "Taylor & Francis",
  "ris": "https://research.draconitic.com/paper/1x0rmcqa030f8.ris",
  "sources": [
    {
      "first_seen": "2026-11-16T12:23:16Z",
      "native_id": "PMC13757678",
      "source": "pmc",
      "url": "https://doi.org/10.1080/21645515.2026.2759393"
    }
  ],
  "subjects": [
    {
      "field": "medicine",
      "origin": "openalex:2713|Influenza Virus Research Studies",
      "subfield": "epidemiology-public-health"
    }
  ],
  "title": "Effectiveness of the 2025–2026 trivalent influenza vaccine against laboratory-confirmed influenza among older adults in Eastern China: A test-negative case–control study",
  "title_text": "Effectiveness of the 2025–2026 trivalent influenza vaccine against laboratory-confirmed influenza among older adults in Eastern China: A test-negative case–control study",
  "type": "peer-reviewed",
  "updated_at": "2026-11-16T12:23:16Z",
  "url": "https://research.draconitic.com/paper/1x0rmcqa030f8",
  "venue": "Human Vaccines & Immunotherapeutics",
  "versions": []
}